ENLIVEN THERAPEUTICS INC (ELVN) Institutional Shareholders

ENLIVEN THERAPEUTICS INC (ELVN) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $2.34B in ELVN holdings during the latest filing period.

Orbimed Advisors Llc is currently the largest disclosed institutional shareholder of ELVN tracked by InsiderSet, reporting ownership valued at approximately $312.01M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $436.26M, representing an estimated gain of +39.82% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 63% of the total disclosed ELVN value among the investors covered in this analysis. Major shareholders include Orbimed Advisors Llc, Fmr Llc, Polar Capital Holdings Plc, and several other long-term asset managers with concentrated positions in ENLIVEN THERAPEUTICS INC (ELVN).

This page ranks the largest institutional ELVN shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

165

Total Reported Value

$2.34B

Largest Holder

Orbimed Advisors Llc

Largest Position

$312.01M

Insider Transactions (90d)

35

Latest Filing Quarter

Q2 2026

New Institutional Positions

188

Funds Exiting Positions

0

Page 1 of 4
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Orbimed Advisors Llc6.80%7,959,538$312,013,890$436,262,278+$124,248,388+39.82%
Fmr Llc0.01%6,829,246$267,706,443$374,310,973+$106,604,530+39.82%
Polar Capital Holdings Plc0.87%5,065,933$198,584,574$277,663,788+$79,079,214+39.82%
Blackrock, Inc.0.00%3,684,707$144,440,514$201,958,791+$57,518,277+39.82%
Commodore Capital Lp7.43%3,275,000$128,380,000$179,502,750+$51,122,750+39.82%
Vestal Point Capital, Lp3.56%3,250,000$127,400,000$178,132,500+$50,732,500+39.82%
Bellevue Group Ag2.17%2,320,867$90,977,986$127,206,720+$36,228,734+39.82%
Fairmount Funds Management Llc5.25%1,855,644$72,741,245$101,707,848+$28,966,603+39.82%
Citadel Advisors Llc0.05%1,743,915$68,361,468$95,583,981+$27,222,513+39.82%
Venrock Adviser, Llc2.53%1,726,331$67,672,175$94,620,202+$26,948,027+39.82%
Pictet Asset Management Holding Sa0.06%1,161,784$58,960,538$63,677,381+$4,716,843+8.00%
Novo Holdings A/S4.07%1,280,000$50,176,000$70,156,800+$19,980,800+39.82%
State Street Corp0.00%1,091,106$42,771,355$59,803,520+$17,032,165+39.82%
Geode Capital Management, Llc0.00%1,066,420$41,813,049$58,450,480+$16,637,431+39.79%
Baker Bros. Advisors Lp0.20%905,191$35,483,487$49,613,519+$14,130,032+39.82%
Rock Springs Capital Management Lp1.91%826,500$32,398,800$45,300,465+$12,901,665+39.82%
Siren, L.L.C.0.81%746,226$29,252,059$40,900,647+$11,648,588+39.82%
Dimensional Fund Advisors Lp0.01%681,715$26,714,134$37,364,799+$10,650,665+39.87%
First Turn Management, Llc2.73%623,839$24,454,489$34,192,616+$9,738,127+39.82%
Candriam S.C.A.0.12%594,079$23,287,897$32,561,470+$9,273,573+39.82%
Jones Hill Capital Lp4.98%593,040$23,247,168$32,504,522+$9,257,354+39.82%
Affinity Asset Advisors, Llc1.35%586,904$23,006,637$32,168,208+$9,161,571+39.82%
Logos Global Management Lp1.09%540,000$21,168,000$29,597,400+$8,429,400+39.82%
Morgan Stanley0.00%518,572$20,328,037$28,422,931+$8,094,894+39.82%
Goldman Sachs Group Inc0.00%473,115$18,546,108$25,931,433+$7,385,325+39.82%
Avidity Partners Management Lp3.73%400,000$16,492,000$21,924,000+$5,432,000+32.94%
Assenagon Asset Management S.A.0.02%306,574$15,558,631$16,803,321+$1,244,690+8.00%
Northern Trust Corp0.00%372,316$14,594,788$20,406,640+$5,811,852+39.82%
Caption Management, Llc0.69%370,000$14,504,000$20,279,700+$5,775,700+39.82%
Stempoint Capital Lp2.78%363,438$14,246,770$19,920,037+$5,673,267+39.82%
Charles Schwab Investment Management Inc0.00%360,577$14,134,618$19,763,225+$5,628,607+39.82%
Millennium Management Llc0.01%345,318$13,536,466$18,926,880+$5,390,414+39.82%
Adar1 Capital Management, Llc0.78%329,540$12,917,968$18,062,087+$5,144,119+39.82%
Spruce Street Capital Lp3.10%329,006$12,897,035$18,032,819+$5,135,784+39.82%
Balyasny Asset Management L.P.0.02%310,025$12,152,980$16,992,470+$4,839,490+39.82%
Jennison Associates Llc0.01%309,180$12,119,856$16,946,156+$4,826,300+39.82%
Alliancebernstein L.P.0.00%771,885$11,887,029$42,307,017+$30,419,988+255.91%
Woodline Partners Lp0.04%301,673$11,825,582$16,534,697+$4,709,115+39.82%
Ubs Group Ag0.00%283,544$11,114,925$15,541,047+$4,426,122+39.82%
Soleus Capital Management, L.P.0.37%230,869$9,050,065$12,653,930+$3,603,865+39.82%
Exome Asset Management Llc5.08%220,091$8,627,567$12,063,188+$3,435,621+39.82%
Schonfeld Strategic Advisors Llc0.07%218,867$8,579,586$11,996,100+$3,416,514+39.82%
First Light Asset Management, Llc0.71%201,867$7,913,186$11,064,330+$3,151,144+39.82%
Patient Square Capital Lp1.39%200,000$7,840,000$10,962,000+$3,122,000+39.82%
D. E. Shaw & Co., Inc.0.01%193,531$7,586,415$10,607,434+$3,021,019+39.82%
Connor, Clark & Lunn Investment Management Ltd.0.02%191,293$7,498,686$10,484,769+$2,986,083+39.82%
Nicholas Investment Partners, Lp0.52%182,728$7,162,938$10,015,322+$2,852,384+39.82%
Seven Fleet Capital Management Lp2.04%164,030$6,429,976$8,990,484+$2,560,508+39.82%
Jane Street Group, Llc0.01%163,519$6,409,946$8,962,476+$2,552,530+39.82%
Ameriprise Financial Inc0.00%160,577$6,294,619$8,801,225+$2,506,606+39.82%

Frequently asked questions about ELVN

  • Who owns the most ELVN stock?

    The largest holders of ELVN are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ENLIVEN THERAPEUTICS INC (ELVN).

  • Is ELVN widely held by superinvestors?

    Many widely followed stocks like ELVN appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly ELVN is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.